Sally Siegfried

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: India

Consulting Services

IT-Web-Mobile Technology Grant Submission Data Science-Bioinformatics Journal Manuscript Admin and Customer Support

Areas Of Interest

Receptor, Heat-Stable Enterotoxin Electroencephalographies, Intracranial Control, Population Mass Administrations Antibodies, Bispecific Deficiencies, Riboflavin CD4-Positive T-Lymphocytopenia, Idiopathic Germplasm Banks Methodologies, Genotype Assignment Classes, Antibody Binding Proteins, Cap Negative-Pressure Therapies, Topical Port Wine Stain Versive Seizure Teas, Java gamma Scorpion Toxin Elastomers Chemokine (C-X-C Motif) Ligand 5 Protein Granix Echocardiography, 3D Dibromomannitol Closed Cohort Studies Human Chemosignals Deficiency Disease, Phenylalanine Hydroxylase, Severe Leukemias, Plasmacytic beta Chain, beta-N-Acetylhexosaminidase Acoustic Waves Facioauriculovertebral Sequence Celestial Star N-Myc Proto-Oncogene Protein Kinases, Proline-Directed Protein Anionic Neutrophil Activating Peptide

Professional Narrative

Dr. Sally Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 1999
Assistant Professor, Harvard Med 1994

Education

Master of Science in physician assistant, Perelman School of Medicine 1987
Bachelor of science in nursing, Yale School of Medicine 2013

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :